454 related articles for article (PubMed ID: 24729433)
1. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
2. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
Clin Infect Dis; 2017 Oct; 65(8):1316-1326. PubMed ID: 28531260
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
5. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
[TBL] [Abstract][Full Text] [Related]
6. The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.
Blumenthal MJ; Schutz C; Barr D; Locketz M; Marshall V; Whitby D; Katz AA; Uldrick T; Meintjes G; Schäfer G
J Infect Dis; 2019 Jul; 220(5):841-851. PubMed ID: 31004430
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America.
Castilho JL; Kim A; Jenkins CA; Grinsztejn B; Gotuzzo E; Fink V; Padgett D; Belaunzaran-Zamudio PF; Crabtree-Ramírez B; Escuder MM; Souza RA; Tenore SB; Pimentel SR; Ikeda MLR; de Alencastro PR; Tupinanbas U; Brites C; Luz E; Netto J; Cortes CP; Grangeiro A; Shepherd BE; McGowan CC;
J Int AIDS Soc; 2021 Jan; 24(1):e25658. PubMed ID: 33405281
[TBL] [Abstract][Full Text] [Related]
9. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
11. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
[TBL] [Abstract][Full Text] [Related]
13. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
[TBL] [Abstract][Full Text] [Related]
14. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
[TBL] [Abstract][Full Text] [Related]
15. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
Labo N; Miley W; Benson CA; Campbell TB; Whitby D
AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa.
Mosam A; Hurkchand HP; Cassol E; Page T; Cassol S; Bodasing U; Aboobaker J; Dawood H; Friedland GH; Coovadia HM
Int J STD AIDS; 2008 Jun; 19(6):400-5. PubMed ID: 18595878
[TBL] [Abstract][Full Text] [Related]
20. EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.
Blumenthal MJ; Schutz C; Meintjes G; Mohamed Z; Mendelson M; Ambler JM; Whitby D; Mackelprang RD; Carse S; Katz AA; Schäfer G
Cancer Epidemiol; 2018 Oct; 56():133-139. PubMed ID: 30176543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
